Aura Biosciences, Inc.
AURA
$6.51
$0.213.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.73M | 5.73M | 5.69M | 5.47M | 6.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.91M | 28.61M | 29.04M | 27.81M | 23.23M |
| Operating Income | -27.91M | -28.61M | -29.04M | -27.81M | -23.23M |
| Income Before Tax | -26.10M | -26.97M | -27.47M | -25.81M | -21.00M |
| Income Tax Expenses | 26.00K | 48.00K | 18.00K | 24.00K | 43.00K |
| Earnings from Continuing Operations | -26.13M | -27.02M | -27.48M | -25.83M | -21.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.13M | -27.02M | -27.48M | -25.83M | -21.04M |
| EBIT | -27.91M | -28.61M | -29.04M | -27.81M | -23.23M |
| EBITDA | -27.63M | -28.33M | -28.74M | -27.52M | -22.92M |
| EPS Basic | -0.40 | -0.47 | -0.55 | -0.52 | -0.42 |
| Normalized Basic EPS | -0.25 | -0.29 | -0.34 | -0.32 | -0.26 |
| EPS Diluted | -0.40 | -0.47 | -0.55 | -0.52 | -0.42 |
| Normalized Diluted EPS | -0.25 | -0.29 | -0.34 | -0.32 | -0.26 |
| Average Basic Shares Outstanding | 65.94M | 58.02M | 50.13M | 49.94M | 49.66M |
| Average Diluted Shares Outstanding | 65.94M | 58.02M | 50.13M | 49.94M | 49.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |